Education
About Us
Working with TipRanks
Follow Us
Balchem Corp. (BCPC)
NASDAQ:BCPC
BCPC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$137.69 - $186.03
Previous CloseN/A
Volume32.16K
Average Volume (3M)175.33K
Market Cap
$5.31B
Enterprise Value$5.94B
Total Cash (Recent Filing)$49.52M
Total Debt (Recent Filing)$34.05M
Price to Earnings (P/E)41.9
Beta0.94
Next Earnings
Apr 25, 2025EPS Estimate
1.05Last Dividend Ex-Date
Dec 26, 2024Dividend Yield0.53%
Share Statistics
EPS (TTM)3.93
Shares Outstanding32,532,722
10 Day Avg. Volume215,028
30 Day Avg. Volume175,331
Financial Highlights & Ratios
PEG Ratio2.39
Price to Book (P/B)N/A
Price to Sales (P/S)5.50
Price to Cash Flow (P/CF)25.10
P/FCF Ratio23.30
Enterprise Value/Market Cap1.12
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit17.67
Enterprise Value/Ebitda27.00
Forecast
1Y Price Target
$203.00Price Target Upside22.88% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
Balchem News
PremiumCompany Announcements
Balchem Announces Retirement of Chief Accounting Officer
PremiumCompany Announcements
Balchem Reports Strong 2024 Financial Performance
PremiumCompany Announcements
Balchem’s Strong Earnings and Strategic Growth Outlook
PremiumPre-Earnings
Balchem (BCPC) Q4 Earnings Cheat SheetPremiumCompany Announcements
Balchem Approves Executive Severance Policy and Benefits---
Bulls Say, Bears Say
Bulls Say
Analyst RecommendationAnalyst reiterates a Buy rating and raises the 12-month target to $190 per share.
Product DevelopmentBalchem recently unveiled two new solutions, K2Vital Delta Fermented and VitaCholine Pro-Flo, which are expected to drive uptake and market demand.
Strategic PartnershipsThe partnership with FC Bayern Women marks a key milestone in Balchem’s longer-term strategy to bridge the gap between B2B and B2C markets.
Bears Say
EarningsBalchem's 4Q24 GAAP net earnings came in somewhat below the forecasted amount, indicating a moderate earnings miss.
Financial PerformanceBalchem's 4Q24 and full-year 2024 financial results displayed revenue moderately below estimates.
Segment PerformanceThe HNH division generated 4Q24 revenue well below the estimate.
---
Ownership Overview
0.58% Insiders
30.38% Mutual Funds
26.51% Other Institutional Investors
15.61% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
ProductionRisks related to the company’s ability to manufacture goods and services
BCPC FAQ
What was Balchem Corp.’s price range in the past 12 months?
Balchem Corp. lowest stock price was $137.69 and its highest was $186.03 in the past 12 months.
What is Balchem Corp.’s market cap?
Balchem Corp.’s market cap is $5.31B.
When is Balchem Corp.’s upcoming earnings report date?
Balchem Corp.’s upcoming earnings report date is Apr 25, 2025 which is in 28 days.
How were Balchem Corp.’s earnings last quarter?
Balchem Corp. released its earnings results on Feb 21, 2025. The company reported $1.03 earnings per share for the quarter, missing the consensus estimate of $1.055 by -$0.025.
Is Balchem Corp. overvalued?
According to Wall Street analysts Balchem Corp.’s price is currently Undervalued.
Does Balchem Corp. pay dividends?
Balchem Corp. pays a Annually dividend of $0.87 which represents an annual dividend yield of 0.53%. See more information on Balchem Corp. dividends here
What is Balchem Corp.’s EPS estimate?
Balchem Corp.’s EPS estimate is 1.05.
How many shares outstanding does Balchem Corp. have?
Balchem Corp. has 32,532,722 shares outstanding.
What happened to Balchem Corp.’s price movement after its last earnings report?
Balchem Corp. reported an EPS of $1.03 in its last earnings report, missing expectations of $1.055. Following the earnings report the stock price went up 1.481%.
Which hedge fund is a major shareholder of Balchem Corp.?
Currently, no hedge funds are holding shares in BCPC
---
Balchem Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$203.00 (22.88% Upside)
$203.00 (22.88% Upside)
Blogger Sentiment
Bullish
BCPC Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 927.0 Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
6.87%
12-Months-Change
Fundamentals
Return on Equity
11.66%
Trailing 12-Months
Asset Growth
-1.24%
Trailing 12-Months
Company Description
Balchem Corp.
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.
---
BCPC Company Deck
---
BCPC Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlights Balchem's strong financial results for the year and the fourth quarter, with record sales and earnings, significant growth in key segments, and a continued commitment to dividend growth. However, there were challenges in specific markets and increased operating expenses that slightly dampened the overall positive sentiment.Read More>---
BCPC Stock 12 Month Forecast
Average Price Target
$203.00
▲(22.88% Upside)
Technical Analysis
Best Analysts Covering BCPC
1 Year
1 Year Success Rate
4/7 ratings generated profit
1 Year Average Return
+11.49%
reiterated a buy rating last month
Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +11.49% per trade.
---